{"database": "lobbying", "table": "lobbying_activities", "rows": [[2345598, "3295e71b-29d5-4927-97b8-8e0c6865dfee", "Q3", "FAEGRE BAKER DANIELS CONSULTING", 34158, "MYRIAD GENETICS, INC.", 2019, "third_quarter", "MED", "Draft legislation to regulate clinical labs under CLIA and FDA.", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2019-10-17T09:28:46.067000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2345598"], "units": {}, "query_ms": 0.33485505264252424, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}